Table 1.
Pre‐transplant characteristics of the study population.
| i.d., M/F | Age at Tx (years) | BMI (kg/m2) | FVC, % pred. (start therapy) | DLCO, % pred. | 6MWD (meters) | GAP score, n | mPAP (mmHg) | LAS score, n | Comorbidities |
|---|---|---|---|---|---|---|---|---|---|
| 1, M | 55 | 24 | 43 | 24 | 360 | 5 | 20 | 39 | Arterial hypertension |
| 2, F | 63 | 25 | 55 | 40 | 450 | 5 | 18 | 34 | Reflux; hiatal hernia; previous HCV infection |
| 3, M | 57 | 28 | 40 | 33 | 210 | 5 | 20 | 35 | Osteoporosis |
| 4, M | 48 | 23 | 43 | 36 | 450 | 4 | 17 | 35 | None |
| 5, M | 56 | 28 | 48 | 25 | 270 | 5 | 25 | 39 | Dyslipidaemia; OSA |
| 6, M | 60 | 25 | 53 | 22 | 454 | 4 | 26 | 40.7 | Coronary artery disease post‐stenting |
| 7, M | 65 | 25 | 81 | 19 | 144 | 4 | 25 | 32.2 | None |
| 8, M | 66 | 22 | 43 | 30 | 505 | 7 | 22 | 30 | None |
| 9, F | 60 | 29 | 59 | 24 | 390 | 4 | 10 | 33.7 | Carotid artery disease; hiatal hernia |
| Mean ± SD | 59 ± 5.6 | 25 ± 3.5 | 51.6 ± 12.7 | 28 ± 7 | 359 ± 124 | 4.7 ± 0.9 | 20.3 ± 5.0 | 35.6 ± 3.7 |
6MWD, 6‐min walk distance; BMI, body mass index; DLCO, diffusing capacity of the lung for carbon monoxide; F, female; FVC, forced vital capacity; GAP, gender‐age‐physiology; HCV, hepatitis C virus; i.d., patient identification number; LAS, lung allocation score; M, male; mPAP, mean pulmonary artery pressure; OSA, obstructive sleep apnoea; pred., predicted; SD, standard deviation; Tx, treatment.